Moisés León-Ruiz

Dr. Moisés León-Ruiz

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Neurología
Verified
Journal Article
Open access
MLMoisés León-Ruiz
Moisés León-Ruiz
MSM.L. Rodríguez Sarasa
M.L. Rodríguez Sarasa
LRL. Sanjuán Rodríguez
L. Sanjuán Rodríguez
JBJ. Benito-León
J. Benito-León
ERE. García-Albea Ristol
E. García-Albea Ristol
SAS. Arce Arce
S. Arce Arce
Repetitive transcranial magnetic stimulation (rTMS) is a therapeutic reality in post-stroke rehabilitation. It has a neuroprotective effect on the modulation of neuroplasticity, improving the brain's capacity to retrain neural circuits and promoting restoration and acquisition of new compensatory skills. We conducted a literature search on PubMed and also gathered the latest books, clinical practice guidelines, and recommendations published by the most prominent scientific societies concerning the therapeutic use of rTMS in the rehabilitation of stroke patients. The criteria of the International Federation of Clinical Neurophysiology (2014) were followed regarding the inclusion of all evidence and recommendations. Identifying stroke patients who are eligible for rTMS is essential to accelerate their recovery. rTMS has proven to be safe and effective for treating stroke complications. Functional brain activity can be optimised by applying excitatory or inhibitory electromagnetic pulses to the hemisphere ipsilateral or contralateral to the lesion, respectively, as well as at the level of the transcallosal pathway to regulate interhemispheric communication. Different studies of rTMS in these patients have resulted in improvements in motor disorders, aphasia, dysarthria, oropharyngeal dysphagia, depression, and perceptual-cognitive deficits. However, further well-designed randomized controlled clinical trials with larger sample size are needed to recommend with a higher level of evidence, proper implementation of rTMS use in stroke subjects on a widespread basis.

1 April 2022 in Neurología (English Edition)
Verified
Journal Article
Open access
MLMoisés León-Ruiz
Moisés León-Ruiz
MSM. Sospedra
M. Sospedra
SAS. Arce Arce
S. Arce Arce
JTJ. Tejeiro-Martínez
J. Tejeiro-Martínez
JBJ. Benito-León
J. Benito-León
A growing number of studies have evaluated the effects of transcranial magnetic stimulation (TMS) for the symptomatic treatment of multiple sclerosis (MS). We performed a PubMed search for articles, recent books, and recommendations from the most relevant clinical practice guidelines and scientific societies regarding the use of TMS as symptomatic treatment in MS. Excitatory electromagnetic pulses applied to the affected cerebral hemisphere allow us to optimise functional brain activity, including the transmission of nerve impulses through the demyelinated corticospinal pathway. Various studies into TMS have safely shown statistically significant improvements in spasticity, fatigue, lower urinary tract dysfunction, manual dexterity, gait, and cognitive deficits related to working memory in patients with MS; however, the exact level of evidence has not been defined as the results have not been replicated in a sufficient number of controlled studies. Further well-designed, randomised, controlled clinical trials involving a greater number of patients are warranted to attain a higher level of evidence in order to recommend the appropriate use of TMS in MS patients across the board. TMS acts as an adjuvant with other symptomatic and immunomodulatory treatments. Additional studies should specifically investigate the effect of conventional repetitive TMS on fatigue in these patients, something that has yet to see the light of day.

1 April 2022 in Neurología
Verified
Journal Article
Open access
MLMoisés León-Ruiz
Moisés León-Ruiz
MSM. Sospedra
M. Sospedra
SAS. Arce Arce
S. Arce Arce
JTJ. Tejeiro-Martínez
J. Tejeiro-Martínez
JBJ. Benito-León
J. Benito-León
A growing number of studies have evaluated the effects of transcranial magnetic stimulation (TMS) for the symptomatic treatment of multiple sclerosis (MS). We performed a PubMed search for articles, recent books, and recommendations from the most relevant clinical practice guidelines and scientific societies regarding the use of TMS as symptomatic treatment in MS. Excitatory electromagnetic pulses applied to the affected cerebral hemisphere allow us to optimise functional brain activity, including the transmission of nerve impulses through the demyelinated corticospinal pathway. Various studies into TMS have shown statistically significant improvements in spasticity, fatigue, lower urinary tract dysfunction, manual dexterity, gait, and cognitive deficits related to working memory in patients with MS; however, the exact level of evidence has not been defined as the results have not been replicated in a sufficient number of controlled studies. Further well-designed, randomised, controlled clinical trials involving a greater number of patients are warranted to attain a higher level of evidence in order to recommend the appropriate use of TMS in MS patients across the board. TMS acts as an adjuvant with other symptomatic and immunomodulatory treatments. Additional studies should specifically investigate the effect of conventional repetitive TMS on fatigue in these patients, something that has yet to see the light of day.

1 April 2019 in Neurología
Verified
Journal Article
Open access
MLMoisés León-Ruiz
Moisés León-Ruiz
MSM.L. Rodríguez Sarasa
M.L. Rodríguez Sarasa
LRL. Sanjuán Rodríguez
L. Sanjuán Rodríguez
MNM.T. Pérez Nieves
M.T. Pérez Nieves
FEF. Ibáñez Estéllez
F. Ibáñez Estéllez
JBJ. Benito-León
J. Benito-León
Very little has been written on seizure management in palliative care (PC). Given this situation, and considering the forthcoming setting up of the Palliative Care Unit at our neurorehabilitation centre, the Clínica San Vicente, we decided to establish a series of guidelines on the use of antiepileptic drugs (AEDs) for handling seizures in PC. We conducted a literature search in PubMed to identify articles, recent manuals, and clinical practice guidelines on seizure management in PC published by the most relevant scientific societies. Clinical practice guidelines are essential to identify patients eligible for PC, manage seizures adequately, and avoid unnecessary distress to these patients and their families. Given the profile of these patients, we recommend choosing AEDs with a low interaction potential and which can be administered by the parenteral route, preferably intravenously. Diazepam and midazolam appear to be the most suitable AEDs during the acute phase whereas levetiracetam, valproic acid, and lacosamide are recommended for refractory cases and long-term treatment. These guidelines provide general recommendations that must be adapted to each particular clinical case. Nevertheless, we will require further well-designed randomised controlled clinical trials including large samples of patients eligible for PC to draft a consensus document recommending adequate, rational, and effective use of AEDs, based on a high level of evidence, in this highly complex area of medical care.

1 January 2016 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
MLMoisés León-Ruiz
Moisés León-Ruiz
Ruiz ML. J Clin Neurol. 2016 Apr;12(2):248-250. http://dx.doi.org/10.3988/jcn.2016.12.2.248

12 December 2023 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
MLMoisés León-Ruiz
Moisés León-Ruiz
JBJulián Benito-León
Julián Benito-León
CCCarlos Castañeda-Cabrero
Carlos Castañeda-Cabrero